Strikingly, Dkk3‐null cancer cells led to an increase in myCAF gene expression (ACTA2, CTGF, PDGFRB), with concomitant downregulation of inflammatory CAF markers (CXCL12, CXCL2) in PSCs (Figure 4J). The gene discussed is ACTA2; the disease is cancer.